Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Sangamo Therapeutics partners with Genentech for genomic medicines development

Dec 15, 2024•over 1 year ago

Contract Type

partnership

BrisbaneBiotechnologyHealth CareGeneticsTherapeutics

Description

Sangamo Therapeutics has entered a global license agreement with Genentech to develop genomic medicines for neurodegenerative diseases, which focuses on the tau gene related to Alzheimer's disease and other tauopathies. This partnership includes a $50 million upfront payment and potential milestone payments of up to $1.9 billion, extending Sangamo's financial runway into the first quarter of 2025.

Company Information

Company

Sangamo Therapeutics

Location

Brisbane, California, United States

About

Sangamo Therapeutics, Inc. is a genomic medicine company based in California.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Sangamo Therapeutics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.